AGP Executive Report

Geneva Health & Tech Diplomacy: President Lula met Switzerland’s Guy Parmelin and France’s Emmanuel Macron, agreeing to expand cooperation on artificial intelligence, energy, health, and defense—with the Mercosur–EFTA deal framed as a hedge against protectionism. Nuclear Safety & Public Health: A wide coalition of countries, including Liechtenstein, condemned a May 17 drone attack on electrical infrastructure near the Barakah Nuclear Plant, warning of potential radiological, environmental, and human health risks. Local Wellness Spotlight: International Yoga Day celebrations in Switzerland set a Guinness record for the most viewers in a YouTube Live yoga stream, linking yoga with wellbeing and mindfulness for diaspora and local communities. Healthcare Access Abroad: A UK travel-health reminder: many people risk expensive bills overseas without a GHIC, which can help cover state-provided care in parts of Europe for eligible travelers. Policy Pressure on Mobility: Switzerland’s upcoming population-cap referendum could tighten migration and free-movement rules—an issue that can indirectly affect access to services, including healthcare. Med Tech Update: Medexus secured Canadian rights to a European-conditional cell therapy (Zemcelpro®/UM171), targeting blood cancers and aiming for commercialization later.

Nuclear Safety & Health: A large coalition of countries, including Liechtenstein, issued a joint condemnation of a May 17 drone attack targeting electrical infrastructure outside the inner perimeter of the Barakah Nuclear Energy Plant in the UAE, warning of risks to civilian life and potential transboundary radiological, environmental, and health impacts. Wellbeing & Community: International Yoga Day celebrations in Basel saw India’s embassy and the AYUSH Ministry set a Guinness World Record for the most viewers for a YouTube Live Yoga stream, highlighting yoga as a shared wellbeing and mindfulness practice. Healthcare Access Abroad: A UK travel-insurance warning says nearly half of Brits risk costly medical bills overseas by not having a GHIC, which can help cover state-provided emergency and some routine care in Europe. Policy & Migration: Switzerland’s upcoming population-cap referendum could affect free movement rules tied to EU relations, with knock-on implications for residents and expats. Trade & Pharma: India’s Commerce Minister Piyush Goyal is set to visit Switzerland to push implementation of the India-EFTA TEPA, including cooperation with Swiss pharma and biotech. Travel Rules: The U.S. is advising travelers that ETIAS authorization is expected to launch in late 2026, and a valid passport won’t guarantee entry.

Nuclear Safety & Health: A large group of countries, including Liechtenstein, issued a joint statement condemning a May 17 drone attack on electrical infrastructure outside the Barakah Nuclear Plant in the UAE, warning it violates international law and could pose risks to civilian health and the environment. Wellbeing Culture: International Yoga Day celebrations in Switzerland set a Guinness World Record for the most viewers on a YouTube Live Yoga Stream, with India’s embassy and AYUSH highlighting yoga’s wellbeing and mindfulness benefits. Local Health Policy & Access: A UK travel-insurance warning says almost half of Brits are risking costly medical bills abroad by not having a GHIC, which can help cover state-provided healthcare in Europe for free or at local cost. Healthcare Trade & Pharma: India’s commerce minister Piyush Goyal is in Switzerland to push the India-EFTA TEPA rollout, with discussions explicitly including healthcare and Swiss pharma investment cooperation. Migration Pressure in Europe: Switzerland’s upcoming vote on a 10 million population cap could affect free movement rules that also link to Liechtenstein and broader EU relations, with major knock-on effects for residents and expats. Fintech Spotlight (Liechtenstein): A look at Liechtenstein’s fintech push highlights its strategy of competing via regulation, cross-border access, and digital development rather than relying on a large domestic market.

Refugee Burden Snapshot: A new UNHCR-based ranking shows Lebanon hosting the highest concentration of refugees (131 per 1,000 residents in 2024), with many top countries located near active conflict zones—an important reminder that health and social pressures often follow geography, not wealth. Tax & Relocation Costs: Qatar is named the world’s 4th most affordable tax haven for 2026, after Liechtenstein, Switzerland and Luxembourg—useful for expats weighing financial stress alongside healthcare access. Swiss Migration Vote: Switzerland’s upcoming referendum could cap the population at 10 million, raising questions about how free movement rules—and related services—may shift for people living across the region, including in the Liechtenstein area. Travel Rules for Health Access: The U.S. warns that a valid passport won’t guarantee entry under ETIAS, expected to launch in late 2026; even with approval, entry isn’t automatic. Trade With Healthcare Links: India’s Piyush Goyal is set to push India-EFTA TEPA implementation in Switzerland, including talks with Swiss pharma and biotech—potentially relevant for future medicine supply and cooperation. Holiday Medical Safety: A UK travel-insurance warning highlights that many people lack a GHIC, risking expensive overseas treatment costs—relevant for Liechtenstein residents planning EU trips.

Refugee Health & Access: A new UNHCR-based ranking shows Lebanon hosting the highest refugee burden per capita (131 refugees per 1,000 residents), with many top countries near active conflict zones—an important reminder that health and care capacity often hinges on geography, not just wealth. Travel Health & Paperwork: The U.S. State Department says a valid passport won’t guarantee entry to Europe under ETIAS, expected to launch in late 2026; travelers may still need authorization before visiting 30 Schengen countries, so planning matters for safe access to care abroad. Local Migration Pressure: Switzerland’s upcoming population-cap referendum (10 million) could reshape movement rules in a country tightly linked to the EU via Schengen and free movement—potentially affecting cross-border health access for residents and workers. Healthcare Trade & Pharma: India’s Piyush Goyal is set to push implementation of the India-EFTA TEPA in Switzerland, with meetings involving Swiss pharma and biotech—relevant for future healthcare supply, investment, and collaboration. Liechtenstein Digital Economy: A look at Liechtenstein’s 2026 fintech and digital push highlights how the principality is betting on regulation and cross-border access—signals that could influence health-sector tech and services. Overseas Medical Costs: A UK-focused report warns many travelers lack a GHIC, risking expensive medical bills abroad; it’s a practical reminder for anyone planning healthcare needs while traveling in Europe.

Health & Travel Costs: A new survey by William Russell ranks Qatar as the 4th most affordable tax haven for 2026, with Liechtenstein, Switzerland and Luxembourg taking the top spots—useful context for expats weighing where to live and how far their pay goes. Migration & Access to Care: Switzerland’s June 14 referendum proposes capping the population at 10 million, with knock-on risks for free movement across the EU/Schengen area—an issue that could affect day-to-day life for hundreds of thousands of expats, including access to services. Cross-Border Health & Pharma Ties: India’s Commerce Minister Piyush Goyal is visiting Switzerland (June 12–13) to push implementation of the India-EFTA TEPA, including talks with Swiss pharma and biotech leaders—potentially relevant for future healthcare cooperation. Travel Rules for 2026: The U.S. State Department says ETIAS travel authorization for visa-exempt Americans is expected to launch in late 2026, but approval won’t guarantee entry—important for anyone planning healthcare-related travel. Local Health Coverage Reminder: A UK-focused report warns many travelers lack a GHIC, risking expensive medical bills abroad—worth a reminder for Liechtenstein residents traveling in Europe.

Swiss Migration Vote: Switzerland’s 14 June referendum could cap the population at 10 million, with a trigger at 9.5 million—raising big questions for free movement across the Schengen area and for ties with the EU. Trade & Health Industry Links: India’s commerce minister Piyush Goyal is in Switzerland (12–13 June) to push the India-EFTA TEPA rollout, including talks with Swiss pharma and biotech leaders—an angle that matters for future healthcare investment and cooperation. Travel Rules for Health Access: The U.S. State Department warns that a valid passport won’t guarantee entry to Europe under upcoming ETIAS rules, expected to launch in late 2026—so travelers should plan ahead for authorization before trips. Cell Therapy Update: Medexus says Europe’s conditional approval for UM171 cell therapy (Zemcelpro®) is now tied to securing exclusive Canadian rights, targeting blood cancers like leukemias and myelodysplasias. Liechtenstein in the Mix: A separate report highlights Liechtenstein’s fintech push, focusing on regulation and cross-border access rather than scale.

Trade & Health Cooperation: India’s Commerce Minister Piyush Goyal kicked off a two-day Switzerland visit to advance the India-EFTA Trade and Economic Partnership Agreement (TEPA), with talks including Swiss President Guy Parmelin and meetings with Swiss pharma and biotech leaders focused on research, innovation, and healthcare cooperation. Travel Rules for Europe: The U.S. State Department says Americans should prepare for ETIAS, expected to launch in the final quarter of 2026, noting that a valid passport won’t guarantee entry—visa-free travelers will still need travel authorization for many Schengen countries. Space Health Research: A Caribbean life sciences experiment launched from Sweden aims to study how human immune cells respond to gravity changes, with partners including the University of Zurich and the Centre for Space and Aviation Switzerland and Liechtenstein. Visa Pressure on Russians: Eleven EU countries are urging stricter, more unified visa rules for Russian citizens amid rising Schengen visa issuance.

Trade & Pharma Ties: India’s Commerce Minister Piyush Goyal has started a two-day Switzerland visit in Berne to push implementation of the India–EFTA Trade and Economic Partnership Agreement (TEPA), including talks with Swiss President Guy Parmelin, state officials, and leaders from the Swiss pharmaceutical and biotech sector. Local Relevance for Liechtenstein: Because TEPA covers the EFTA group that includes Liechtenstein, the focus on “operational issues” and smoother trade and investment could directly shape how health-related goods and services move across the region. EU Pressure on Mobility: A Swiss referendum on a population cap is raising alarm in Brussels, with concerns it could strain free movement rules that underpin wider EU–EFTA cooperation. Health Access Abroad: A UK travel warning highlights that many people still lack a GHIC, which can help cover state-provided medical care in Europe at local cost—an issue that matters for Liechtenstein residents traveling nearby. New Cell Therapy Deal: Medexus says it secured exclusive Canadian rights for UM171 cell therapy (Zemcelpro®) after Europe’s conditional authorization, signaling continued momentum in advanced blood-cancer treatments.

Trade & Pharma Ties: India’s Commerce Minister Piyush Goyal will visit Switzerland (Berne, June 12–13) to push the India–EFTA Trade and Economic Partnership Agreement (TEPA) rollout, including talks with Swiss officials and leaders of the Swiss pharmaceutical industry—an effort that also directly involves Liechtenstein as part of the EFTA group. Health & Access Abroad: A UK travel health warning says nearly half of Brits lack a GHIC, which can help cover state-provided medical care in Europe at local cost—urging travellers to get it before departure and still keep travel insurance. EU Migration Pressure: Switzerland’s upcoming vote on a population cap could strain EU relations, with Brussels stressing that free movement is central to the relationship. Medical Innovation: Medexus says Europe’s conditional approval for a cell therapy (Zemcelpro®/dorocubicel) is now tied to a Canada license and supply deal, with commercialization expected from 2028. Liechtenstein in the News: A piece on Liechtenstein highlights how the principality is leaning on regulation and cross-border access to grow its fintech ambitions despite its small size. Science & Health Research: A new space life sciences experiment launched from Sweden includes a partnership with Switzerland and Liechtenstein, studying how human immune cells respond to gravity changes.

India–EFTA Trade Push: Commerce minister Piyush Goyal is set to visit Switzerland next week to speed up the India–EFTA TEPA rollout, with talks in Berne and meetings planned with Swiss officials and the pharmaceutical industry to iron out implementation issues and expand trade and investment. Liechtenstein Fintech Focus: A new look at Liechtenstein’s 2026 strategy highlights how the tiny principality is leaning on regulation, cross-border access, and digital development to punch above its weight in global finance. Space & Health Research Link: Nevis launched the Caribbean’s first space life sciences experiment, partnering with the University of Zurich and the Centre for Space and Aviation Switzerland and Liechtenstein, aiming to study how gravity changes affect human immune cells—work that could inform health during long-duration missions. Sports & Wellness Adjacent: Liechtenstein was among teams playing friendlies recently, with Cyprus beating Liechtenstein 2-0 in one match. Travel Health Reminder: A UK-focused warning urges travellers to get a GHIC before trips, noting many people risk higher out-of-pocket medical costs abroad if they’re missing the card.

Sports & Health Travel: With the 2026 World Cup kicking off in 48 hours, a UK travel-insurance warning is getting attention: almost half of Brits risk costly medical bills abroad by not having a GHIC (Global Health Insurance Card), which can help cover state-provided care in Europe at local cost—though it doesn’t replace travel insurance. Pharma & Bone Health: CinnaGen says it has become the first Iranian pharma company to win EU approval for its osteoporosis medicine teriparatide (Zandoriah), following EMA review under EU biosimilar rules. Liechtenstein in the Mix (Sports Governance): Liechtenstein’s Alexander Ospelt is in the running for FIS president, as Johan Eliasch argues centralising ski commercial rights has boosted revenues and could raise athlete earnings. Local Wellness & Community: In Virginia, U.S. Rep. Donald Beyer returned to his district for a community potluck after a court restored the prior map—an example of how local civic life keeps moving even amid political shifts. Science & Human Health: Nevis launched the Caribbean’s first space life sciences experiment, studying how gravity changes affect human immune cells, with collaboration involving the University of Zurich and CSA Switzerland and Liechtenstein.

Travel Health Costs: A UK finance expert warns nearly half of Brits could face costly medical bills abroad because they don’t have a GHIC (Global Health Insurance Card), which can help cover state healthcare in Europe at local cost—though it doesn’t replace travel insurance. Pharma & Osteoporosis: CinnaGen became the first Iranian pharma firm to get EU approval for its osteoporosis medicine teriparatide (Zandoriah), following EMA review under EU biosimilar rules. Liechtenstein in Sports: In international friendlies, Cyprus beat Liechtenstein 2-0, adding to the week’s match results. Pet Health Tech: Fi, maker of AI GPS pet wearables, expanded coverage to 38 countries, including Switzerland and Liechtenstein, aiming to give owners health insights and tracking while traveling. Health Research in Space: Nevis launched the Caribbean’s first space life sciences experiment, studying how gravity changes affect human immune cells—developed with the University of Zurich and the Centre for Space and Aviation Switzerland and Liechtenstein.

Travel Health Costs: A UK finance expert warns that almost half of Brits risk expensive medical bills abroad because they skip the free GHIC, which can unlock state-provided care in Europe (at local cost or free) for emergencies and some pre-existing conditions—though it doesn’t replace travel insurance. Liechtenstein in the Region: A Swiss trade deal that cut tariffs from 39% to 15% is also tied to Liechtenstein via the customs union, with major pharma investment flows highlighted by Roche and Novartis. Space & Human Health Research: Nevis launched the Caribbean’s first space life sciences experiment on May 31, studying how microgravity and hypergravity affect human immune cells—built with the University of Zurich and the Centre for Space and Aviation Switzerland and Liechtenstein. Pet Health Tech: Fi expanded its AI-powered GPS pet wearables to 38 countries, including Switzerland and Liechtenstein, aiming to pair health insights with reliable tracking for owners who travel. Community & Wellness: Two cyclists plan a Rhine Cycle Route fundraiser for a baby-loss bereavement suite at Southmead Hospital, linking physical activity with support for families.

Travel Health Access: A UK travel warning is going around: nearly half of Brits don’t have a GHIC, risking out-of-pocket medical bills abroad. The Global Health Insurance Card can help cover state-provided care in Europe (often at local cost or free), but it doesn’t replace travel insurance. Pharma in Europe: The European Commission has approved CinnaGen’s teriparatide (Zandoriah) for osteoporosis, marking a first for an Iranian company in the EU. Cancer Treatment Update: Europe has also approved Opdivo (nivolumab) plus AVD chemotherapy as the first immunotherapy-based regimen for newly diagnosed advanced classical Hodgkin lymphoma in patients aged 12+. Research & Health in Space: Nevis launched the Caribbean’s first space life sciences experiment, studying how microgravity and hypergravity affect human immune cells—aimed at improving health knowledge for long-duration missions. Liechtenstein Link: A Swiss trade deal that includes Liechtenstein is driving major pharma investment into the US, with Roche and Novartis leading large commitments.

Pharma Investment & Access: Swiss firms are accelerating US spending after a trade deal cut tariffs on Swiss goods from 39% to 15%, with Roche pledging $50B and Novartis $23B—an update that also matters for Liechtenstein via the customs union. Cancer Care Update: The European Commission approved Opdivo (nivolumab) plus AVD chemotherapy as the first immunotherapy-based regimen in the EU for newly diagnosed advanced classical Hodgkin lymphoma in patients aged 12+—a meaningful step for treatment options. Space Health Research: Nevis launched the Caribbean’s first space life sciences experiment, developed with the University of Zurich and CSA Switzerland and Liechtenstein, to study how gravity changes affect human immune cells and gene expression. Local Wellness Tech: Fi expanded AI-powered GPS pet wearables to 38 countries, including Switzerland and Liechtenstein, pairing health insights with real-time tracking for pet owners on the move. Travel Health Practicalities: A UK travel warning highlights that without a GHIC card, travellers may miss state-provided medical treatment abroad at local cost, so applying before travel is key.